[HTML][HTML] Endothelial lipase provides an alternative pathway for FFA uptake in lipoprotein lipase–deficient mouse adipose tissue

D Kratky, R Zimmermann, EM Wagner… - The Journal of …, 2005 - Am Soc Clin Investig
D Kratky, R Zimmermann, EM Wagner, JG Strauss, W Jin, GM Kostner, G Haemmerle…
The Journal of clinical investigation, 2005Am Soc Clin Investig
Lipoprotein lipase (LPL) is thought to be the only enzyme responsible for the catabolism of
triglycerides (TGs) associated with TG-rich lipoproteins in adipose tissue (AT). However, LPL
deficiency in humans and induced mutant mice is not associated with decreased fat mass.
We investigated whether endothelial lipase (EL), a recently discovered phospholipase,
might represent an alternative mechanism for the uptake of phospholipid-derived fatty acids
in murine lipoprotein-deficient AT. When LPL was expressed in AT and isolated murine …
Lipoprotein lipase (LPL) is thought to be the only enzyme responsible for the catabolism of triglycerides (TGs) associated with TG-rich lipoproteins in adipose tissue (AT). However, LPL deficiency in humans and induced mutant mice is not associated with decreased fat mass. We investigated whether endothelial lipase (EL), a recently discovered phospholipase, might represent an alternative mechanism for the uptake of phospholipid-derived fatty acids in murine lipoprotein-deficient AT. When LPL was expressed in AT and isolated murine adipocytes, EL mRNA was not detectable. In contrast, mouse AT and isolated adipocytes that lacked LPL expressed large amounts of EL mRNA. The cellular phospholipase activity in LPL-deficient fat pads was increased 4-fold compared with control fat pads and could be inhibited to control levels by a specific EL antibody. Fatty acids produced by EL activity were absorbed by adipocytes and incorporated into the TG moiety of AT. Our results suggest that EL activity in AT and other peripheral tissues might contribute to the tissue uptake of free fatty acids, which could have important implications for the metabolism of plasma lipoproteins.
The Journal of Clinical Investigation